Posted in | News | Optics and Photonics

NASA Selects ODIS' PlanarOptoElectric Technology Platform for Space Missions

ODIS has secured a development contract from NASA that will comprise a Phase I Award of $100,000. NASA has selected ODIS' PlanarOptoElectric Technology (POET) platform as an ideal technique to build Optoelectronic infrastructure for Optical/RF phased array sensors.

Advanced sensors in space need both mmw (millimeter wave) sensing at 35 GHz and optical sensing at 1.5 µm. Usually, individual emitting openings are needed for the RF and optical operations. ODIS will create the POET to integrate the optical transmit and RF beams for phased array sensors into one monolithic circuit, with every circuit offering a pixel of the RF array.

The POET will allow on-chip electronic control of both optical and RF beam steering angles. A huge number of similar spacecraft sensors will be installed in extended space missions that will improve reliability and remove both power and weight.

The President of ODIS, Leon M. Pierhal commented that small phased array sensors with optical and RF emission have huge commercial market in aviation, security and free space optics communication industries. These active sensors complement conventional visible and IR imagers, he added.

ODIS' latest proprietary semiconductor production procedure is the PlanarOptoElectric Technology. The POET is a Group III-V substances system that backs monolithic production of integrated circuits comprising passive and active optical components as well as digital and analog components. A cost-effective combination of multiple optical equipment along with low power, ultra-speed digital, heavy,and ultra-speed analog components is possible in monolithic integrated circuits.

The POET enables ODIS to change the background for a wide range of applications solutions by introducing components that are low-cost ad exhibit high density, speed and durability.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.